SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

EBITDA Growth

-1796.67%

TTM · Period ending:

DMRA logo

DMRA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-1796.67%
DMRA TTM EBITDA YoY % (-61.40% → -1796.67%)
High-resolution chart · PNG

What is ebitda growth?

Year-over-year EBITDA growth rate.

DMRA ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters. Change compares each value with the period before it, in percentage points.

Damora Therapeutics, Inc. EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA GrowthChange
-1,796.6738%−282.43 pts
-1,514.2485%−330.75 pts
-1,183.4936%−292.12 pts
-891.3744%−914.83 pts
23.456%−9.48 pts
32.9338%−6.15 pts
39.0806%−4.53 pts
43.6072%−10.66 pts
54.2698%+2.50 pts
51.7723%+4.32 pts
47.4488%+8.82 pts
38.6283%+13.27 pts
25.3589%+11.16 pts
14.1966%+18.36 pts
-4.1595%+14.50 pts
-18.663%+3.69 pts
-22.3484%+4.26 pts
-26.613%+8.60 pts
-35.2138%+26.19 pts
-61.4004%—

Frequently asked questions: DMRA ebitda growth

What is Damora Therapeutics, Inc. (DMRA)'s current ebitda growth?

Damora Therapeutics, Inc. (DMRA)'s latest reported ebitda growth (TTM) is -1796.67% as of Sep 30, 2026. Year-over-year EBITDA growth rate.

How much historical ebitda growth data is available for DMRA?

Stock Alarm Pro provides 20 dated trailing twelve months (ttm) observations for Damora Therapeutics, Inc. (DMRA)'s ebitda growth, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's ebitda growth to peers or set an alert?

You can open DMRA's ebitda growth in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.